HK1139411A1 - Hydroxy sulfonate of quinone compounds and their uses - Google Patents
Hydroxy sulfonate of quinone compounds and their usesInfo
- Publication number
- HK1139411A1 HK1139411A1 HK10106231.4A HK10106231A HK1139411A1 HK 1139411 A1 HK1139411 A1 HK 1139411A1 HK 10106231 A HK10106231 A HK 10106231A HK 1139411 A1 HK1139411 A1 HK 1139411A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- quinone compounds
- hydroxy sulfonate
- sulfonate
- hydroxy
- quinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91497107P | 2007-04-30 | 2007-04-30 | |
PCT/US2008/005656 WO2008134088A1 (en) | 2007-04-30 | 2008-04-30 | Hydroxy sulfonate of quinone compounds and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1139411A1 true HK1139411A1 (en) | 2010-09-17 |
Family
ID=39494644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10106231.4A HK1139411A1 (en) | 2007-04-30 | 2010-06-24 | Hydroxy sulfonate of quinone compounds and their uses |
Country Status (14)
Country | Link |
---|---|
US (1) | US7790765B2 (xx) |
EP (1) | EP2152686B1 (xx) |
JP (1) | JP2010526072A (xx) |
KR (1) | KR20100017483A (xx) |
CN (1) | CN101687835B (xx) |
AU (1) | AU2008246067B2 (xx) |
BR (1) | BRPI0810717A2 (xx) |
CA (1) | CA2685739C (xx) |
DK (1) | DK2152686T3 (xx) |
ES (1) | ES2532656T3 (xx) |
HK (1) | HK1139411A1 (xx) |
MX (1) | MX2009011822A (xx) |
TW (1) | TWI401081B (xx) |
WO (1) | WO2008134088A1 (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009048251A2 (en) * | 2007-10-11 | 2009-04-16 | Mazence Inc. | Pharmaceutical composition containing micronized particles of naphthoquinone-based compound |
KR101405823B1 (ko) * | 2007-12-24 | 2014-06-12 | 주식회사 케이티앤지생명과학 | 녹내장의 치료 및 예방을 위한 약제 조성물 |
KR20090071829A (ko) * | 2007-12-28 | 2009-07-02 | 주식회사 머젠스 | 신장질환의 치료 및 예방을 위한 약제 조성물 |
EP2648721B1 (de) * | 2011-01-31 | 2018-09-19 | LUCOLAS-M.D. Ltd. | Kombinationen von aromatase inhibitoren und antioxidanzien |
US9343930B2 (en) * | 2012-05-25 | 2016-05-17 | Baldor Electric Company | Segmented stator assembly |
JP6538050B2 (ja) * | 2014-07-10 | 2019-07-03 | ロベルト・ボッシュ・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツングRobert Bosch Gmbh | モータモジュール、及びabs液圧ユニット |
WO2016200934A1 (en) * | 2015-06-08 | 2016-12-15 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Mitochondria-targeted lapachone compounds and uses therefor |
US11090389B2 (en) | 2016-10-13 | 2021-08-17 | University of Pittsburgh—of the Commonwealth System of Higher Education | Mitochondrially targeted PARP inhibitor, and uses thereof |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0040506B1 (en) | 1980-05-21 | 1986-08-20 | Teijin Limited | Reactive polymer and process for the preparation thereof |
US4963565A (en) | 1986-07-30 | 1990-10-16 | National Jewish Center For Immunology And Respiratory Medicine | In vivo treatment of mycobacterial infections with 6-cyclo octylamino-5,8-quinoline quinone |
US5120843A (en) | 1987-04-27 | 1992-06-09 | Upjohn | Pharmaceutically active amines |
FI102273B1 (fi) | 1989-09-11 | 1998-11-13 | Eisai Co Ltd | Kinonijohdannaiset, niiden valmistaminen ja niiden farmakologinen käyttö |
JP3111099B2 (ja) | 1991-10-31 | 2000-11-20 | 科学技術振興事業団 | 水溶性高分子化薬剤の製造法 |
US5559156A (en) | 1993-09-30 | 1996-09-24 | Glaxo Wellcome, Inc. | Method for treating animals infected with Babesia spp. |
WO1994004145A1 (en) | 1992-08-21 | 1994-03-03 | Dana Farber Cancer Institute | Treatment of human viral infections |
US5672607A (en) | 1993-01-29 | 1997-09-30 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral naphthoquinone compounds, compositions and uses thereof |
GB2282384B8 (en) | 1993-08-18 | 1997-09-04 | Europ Economic Community | Drug delivery agents incorporating mitomycin |
EP0640609A1 (en) | 1993-08-24 | 1995-03-01 | Ono Pharmaceutical Co., Ltd. | Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species |
US5840900A (en) | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5880131A (en) | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5763625A (en) | 1995-04-25 | 1998-06-09 | Wisconsin Alumni Research Foundation | Synthesis and use of β-lapachone analogs |
US5674900A (en) | 1995-06-06 | 1997-10-07 | Shaman Pharmaceuticals, Inc. | Terpenoid-type quinones for treatment of diabetes |
US6245807B1 (en) | 1995-08-24 | 2001-06-12 | Dana-Farber Cancer Institute | Treatment of human prostate disease |
US5824700A (en) | 1996-02-20 | 1998-10-20 | Wisconsin Alumni Research Foundation | Ortho-quinone derivatives novel synthesis therefor and their use in the inhibition of neoplastic cell growth |
JP3737518B2 (ja) | 1996-03-12 | 2006-01-18 | ピージー−ティーエックスエル カンパニー, エル.ピー. | 水溶性パクリタキセルプロドラッグ |
WO1997041093A1 (en) | 1996-04-30 | 1997-11-06 | Affymax Technologies N.V. | Methods for the synthesis of fmoc protected amines |
US6664288B1 (en) | 1999-04-14 | 2003-12-16 | Dana Farber Cancer Institute, Inc. | Method and composition for the treatment of cancer |
EP1173223A2 (en) | 1999-04-30 | 2002-01-23 | Slil Biomedical Corporation | Conjugates as therapies for cancers and prostate diseases |
US6376470B1 (en) | 1999-09-23 | 2002-04-23 | Enzon, Inc. | Polymer conjugates of ara-C and ara-C derivatives |
AU781735B2 (en) | 1999-10-12 | 2005-06-09 | Cell Therapeutics, Inc. | Manufacture of polyglutamate-therapeutic agent conjugates |
WO2001070275A2 (en) | 2000-03-17 | 2001-09-27 | Cell Therapeutics, Inc. | Polyglutamic acid-camptothecin conjugates and methods of preparation |
JP4244141B2 (ja) | 2000-11-07 | 2009-03-25 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | 血液腫瘍および血液癌を処置する方法 |
US6458974B1 (en) | 2001-01-25 | 2002-10-01 | Cyclis Pharmaceuticals, Inc. | Synthesis of β-lapachone and its intermediates |
US6962944B2 (en) | 2001-07-31 | 2005-11-08 | Arqule, Inc. | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
US7074824B2 (en) | 2001-07-31 | 2006-07-11 | Arqule, Inc. | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
CZ293787B6 (cs) | 2001-12-20 | 2004-07-14 | Zentiva, A.S. | pH senzitivní polymerní konjugáty antracyklinového kancerostatika pro cílenou terapii |
AU2003228666A1 (en) | 2002-04-23 | 2003-11-10 | Case Western Reserve University | Lapachone delivery systems, compositions and uses related thereto |
US6608076B1 (en) | 2002-05-16 | 2003-08-19 | Enzon, Inc. | Camptothecin derivatives and polymeric conjugates thereof |
WO2004006849A2 (en) | 2002-07-15 | 2004-01-22 | Combinatorx, Incorporated | Combinations of drugs for the treatment of neoplasms |
WO2004045557A2 (en) | 2002-11-18 | 2004-06-03 | Arqule, Inc. | Novel lapachone compounds and methods of use thereof |
WO2005082357A1 (en) | 2004-02-20 | 2005-09-09 | Arqule, Inc. | Use of beta-lapachone for treating hematologic tumors |
EP1722775A1 (en) | 2004-02-20 | 2006-11-22 | Arqule, Inc. | Use of beta-lapachone for treating hematologic tumors |
CA2583700A1 (en) | 2004-08-11 | 2006-02-23 | Arqule, Inc. | Quinone prodrug compositions and methods of use |
US8614228B2 (en) | 2004-08-11 | 2013-12-24 | Arqule, Inc. | Quinone prodrug compositions and methods of use |
WO2006128120A2 (en) | 2005-05-26 | 2006-11-30 | Arqule, Inc. | Novel lapachone compounds and methods of use thereof |
-
2008
- 2008-04-30 ES ES08754188.4T patent/ES2532656T3/es active Active
- 2008-04-30 US US12/150,914 patent/US7790765B2/en active Active
- 2008-04-30 BR BRPI0810717A patent/BRPI0810717A2/pt not_active Application Discontinuation
- 2008-04-30 WO PCT/US2008/005656 patent/WO2008134088A1/en active Application Filing
- 2008-04-30 KR KR1020097024913A patent/KR20100017483A/ko not_active Application Discontinuation
- 2008-04-30 MX MX2009011822A patent/MX2009011822A/es active IP Right Grant
- 2008-04-30 EP EP08754188.4A patent/EP2152686B1/en active Active
- 2008-04-30 AU AU2008246067A patent/AU2008246067B2/en active Active
- 2008-04-30 JP JP2010506326A patent/JP2010526072A/ja not_active Withdrawn
- 2008-04-30 TW TW097115955A patent/TWI401081B/zh active
- 2008-04-30 CN CN200880022708.XA patent/CN101687835B/zh active Active
- 2008-04-30 CA CA2685739A patent/CA2685739C/en active Active
- 2008-04-30 DK DK08754188.4T patent/DK2152686T3/en active
-
2010
- 2010-06-24 HK HK10106231.4A patent/HK1139411A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK2152686T3 (en) | 2015-01-12 |
CA2685739C (en) | 2016-06-14 |
JP2010526072A (ja) | 2010-07-29 |
WO2008134088A1 (en) | 2008-11-06 |
ES2532656T3 (es) | 2015-03-30 |
KR20100017483A (ko) | 2010-02-16 |
CN101687835A (zh) | 2010-03-31 |
TW200913986A (en) | 2009-04-01 |
TWI401081B (zh) | 2013-07-11 |
CN101687835B (zh) | 2015-08-19 |
AU2008246067B2 (en) | 2011-10-20 |
EP2152686A1 (en) | 2010-02-17 |
MX2009011822A (es) | 2010-01-14 |
US20090028952A1 (en) | 2009-01-29 |
CA2685739A1 (en) | 2008-11-06 |
EP2152686B1 (en) | 2014-12-17 |
AU2008246067A1 (en) | 2008-11-06 |
BRPI0810717A2 (pt) | 2016-05-24 |
US7790765B2 (en) | 2010-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201000436B (en) | Novel esterases and their use | |
HK1212210A1 (en) | Combined use of 25-hydroxy-vitamin d3 and vitamin d3 d3 25-- d3 | |
EP2191397A4 (en) | ENHANCED REJECTION OF NON-VOCABULARY WORDS | |
IL200576A0 (en) | Inhibitors of rtp801 and their uses | |
IL202664A (en) | Processes for Preparation of 3-Dihlomethyl-1-Methyl-1H-Pyrazole-4-Carbaldehyde and Intermediates | |
HK1139411A1 (en) | Hydroxy sulfonate of quinone compounds and their uses | |
IL206145A0 (en) | Wearable towel | |
GB0719542D0 (en) | Use of cocoa extract | |
IL207589A0 (en) | Combination of vitamin d and 25-hydroxyvitamin d3 | |
EP2147303A4 (en) | MEASURE AND USE OF AN OXIDATIVE CONDITION | |
PL2133419T3 (pl) | Zastosowania beta-dipeptydów cyjanoficyny | |
EP2069477A4 (en) | CHEMOREPULSION OF CELLS | |
HK1137187A1 (en) | Use of tocopherol | |
TWI350155B (en) | Towel | |
EP2062588A4 (en) | COMPOSITION FOR IMPROVING SKIN CONDITION | |
ZA201004979B (en) | Extracts of sclerocarya birrea | |
GB0723972D0 (en) | Use of vitamin B12 | |
GB2452486B (en) | Towel | |
GB201114396D0 (en) | Location of basesation | |
EP2344454A4 (en) | ANTIOXIDATION COMPOUNDS AND METHOD FOR THEIR USE | |
PL384163A1 (pl) | Mikrokapsułki chlomazonu | |
GB0705204D0 (en) | Uses of (S)-clenbuterol | |
PL383759A1 (pl) | Nowe zastosowanie undekan-2-olu | |
PL383760A1 (pl) | Nowe zastosowanie undekan-2-olu | |
PL383758A1 (pl) | Nowe zastosowanie undekan-2-onu |